319 related articles for article (PubMed ID: 20548286)
1. Attenuated progression of diet-induced steatohepatitis in glutathione-deficient mice.
Haque JA; McMahan RS; Campbell JS; Shimizu-Albergine M; Wilson AM; Botta D; Bammler TK; Beyer RP; Montine TJ; Yeh MM; Kavanagh TJ; Fausto N
Lab Invest; 2010 Dec; 90(12):1704-17. PubMed ID: 20548286
[TBL] [Abstract][Full Text] [Related]
2. Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2).
Sharma RS; Harrison DJ; Kisielewski D; Cassidy DM; McNeilly AD; Gallagher JR; Walsh SV; Honda T; McCrimmon RJ; Dinkova-Kostova AT; Ashford MLJ; Dillon JF; Hayes JD
Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):367-398. PubMed ID: 29552625
[TBL] [Abstract][Full Text] [Related]
3. Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient diet.
Zhang YK; Yeager RL; Tanaka Y; Klaassen CD
Toxicol Appl Pharmacol; 2010 Jun; 245(3):326-34. PubMed ID: 20350562
[TBL] [Abstract][Full Text] [Related]
4. The transition from fatty liver to NASH associates with SAMe depletion in db/db mice fed a methionine choline-deficient diet.
Wortham M; He L; Gyamfi M; Copple BL; Wan YJ
Dig Dis Sci; 2008 Oct; 53(10):2761-74. PubMed ID: 18299981
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
[TBL] [Abstract][Full Text] [Related]
6. Monocyte chemoattractant protein-1 deficiency does not affect steatosis or inflammation in livers of mice fed a methionine-choline-deficient diet.
Kassel KM; Guo GL; Tawfik O; Luyendyk JP
Lab Invest; 2010 Dec; 90(12):1794-804. PubMed ID: 20697377
[TBL] [Abstract][Full Text] [Related]
7. Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice.
Sugimoto H; Okada K; Shoda J; Warabi E; Ishige K; Ueda T; Taguchi K; Yanagawa T; Nakahara A; Hyodo I; Ishii T; Yamamoto M
Am J Physiol Gastrointest Liver Physiol; 2010 Feb; 298(2):G283-94. PubMed ID: 19926817
[TBL] [Abstract][Full Text] [Related]
8. Aliskiren attenuates steatohepatitis and increases turnover of hepatic fat in mice fed with a methionine and choline deficient diet.
Lee KC; Chan CC; Yang YY; Hsieh YC; Huang YH; Lin HC
PLoS One; 2013; 8(10):e77817. PubMed ID: 24204981
[TBL] [Abstract][Full Text] [Related]
9. Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis.
Dixon LJ; Berk M; Thapaliya S; Papouchado BG; Feldstein AE
Lab Invest; 2012 May; 92(5):713-23. PubMed ID: 22411067
[TBL] [Abstract][Full Text] [Related]
10. TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation.
Park HS; Song JW; Park JH; Lim BK; Moon OS; Son HY; Lee JH; Gao B; Won YS; Kwon HJ
Autophagy; 2021 Sep; 17(9):2549-2564. PubMed ID: 33190588
[TBL] [Abstract][Full Text] [Related]
11. Lipid metabolism, oxidative stress and cell death are regulated by PKC delta in a dietary model of nonalcoholic steatohepatitis.
Greene MW; Burrington CM; Lynch DT; Davenport SK; Johnson AK; Horsman MJ; Chowdhry S; Zhang J; Sparks JD; Tirrell PC
PLoS One; 2014; 9(1):e85848. PubMed ID: 24454937
[TBL] [Abstract][Full Text] [Related]
12. CCAAT/enhancing binding protein beta deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis.
Rahman SM; Schroeder-Gloeckler JM; Janssen RC; Jiang H; Qadri I; Maclean KN; Friedman JE
Hepatology; 2007 May; 45(5):1108-17. PubMed ID: 17464987
[TBL] [Abstract][Full Text] [Related]
13. Blockade of interleukin-6 signaling enhances hepatic steatosis but improves liver injury in methionine choline-deficient diet-fed mice.
Yamaguchi K; Itoh Y; Yokomizo C; Nishimura T; Niimi T; Fujii H; Okanoue T; Yoshikawa T
Lab Invest; 2010 Aug; 90(8):1169-78. PubMed ID: 20368703
[TBL] [Abstract][Full Text] [Related]
14. Sitagliptin attenuates methionine/choline-deficient diet-induced steatohepatitis.
Jung YA; Choi YK; Jung GS; Seo HY; Kim HS; Jang BK; Kim JG; Lee IK; Kim MK; Park KG
Diabetes Res Clin Pract; 2014 Jul; 105(1):47-57. PubMed ID: 24842243
[TBL] [Abstract][Full Text] [Related]
15. Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis.
Salamone F; Galvano F; Cappello F; Mangiameli A; Barbagallo I; Li Volti G
Transl Res; 2012 Jun; 159(6):477-86. PubMed ID: 22633099
[TBL] [Abstract][Full Text] [Related]
16. Alanyl-Glutamine Protects Mice against Methionine- and Choline-Deficient-Diet-Induced Steatohepatitis and Fibrosis by Modulating Oxidative Stress and Inflammation.
Hu J; Zheng Y; Ying H; Ma H; Li L; Zhao Y
Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145172
[TBL] [Abstract][Full Text] [Related]
17. 4,4-Diallyl curcumin bis(2,2-hydroxymethyl)propanoate ameliorates nonalcoholic steatohepatitis in methionine-choline-deficient diet and Western diet mouse models.
Yang LC; Wang CC; Lee DY; Lin WC; Kuo SC; Juang SH; Hsieh MT
Chem Biol Drug Des; 2024 May; 103(5):e14532. PubMed ID: 38725089
[TBL] [Abstract][Full Text] [Related]
18. Hepatic effects of a methionine-choline-deficient diet in hepatocyte RXRalpha-null mice.
Gyamfi MA; Tanaka Y; He L; Klaassen CD; Wan YJ
Toxicol Appl Pharmacol; 2009 Jan; 234(2):166-78. PubMed ID: 18952117
[TBL] [Abstract][Full Text] [Related]
19. Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet.
Nagasawa T; Inada Y; Nakano S; Tamura T; Takahashi T; Maruyama K; Yamazaki Y; Kuroda J; Shibata N
Eur J Pharmacol; 2006 Apr; 536(1-2):182-91. PubMed ID: 16574099
[TBL] [Abstract][Full Text] [Related]
20. Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice.
Tomita K; Oike Y; Teratani T; Taguchi T; Noguchi M; Suzuki T; Mizutani A; Yokoyama H; Irie R; Sumimoto H; Takayanagi A; Miyashita K; Akao M; Tabata M; Tamiya G; Ohkura T; Hibi T
Hepatology; 2008 Aug; 48(2):458-73. PubMed ID: 18666257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
